Ubs Group Ag Zimmer Biomet Holdings, Inc. Call Options Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$104.47 - $116.17 $313,410 - $348,510	-3,000 Reduced 19.11%	12,700 $1.37 Million
Q2 2024 Aug 13, 2024	SELL	$106.25 - $130.01 $488,750 - $598,046	-4,600 Reduced 22.66%	15,700 $1.7 Million
Q1 2024 May 13, 2024	BUY	$119.98 - $132.61 $2.44 Million - $2.69 Million	20,300 New	20,300 $2.68 Million
Q1 2018 May 15, 2018	SELL	$104.31 - $124.46 $970,083 - $1.16 Million	-9,300 Reduced 20.76%	35,500 $3.87 Million
Q4 2017 Feb 14, 2018	BUY	$105.55 - $120.83 $1.14 Million - $1.3 Million	10,800 Added 31.76%	44,800 $5.41 Million
Q2 2017 Aug 14, 2017	BUY	N/A	34,000	34,000 $4.37 Million

1,079

178M

301K

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $21.9B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.